BRIDGEWAY CAPITAL MANAGEMENT, LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 116 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2015$484,000
-45.4%
70,000
-30.0%
0.01%
-41.2%
Q2 2015$886,000
-40.1%
100,000
-33.3%
0.02%
-45.2%
Q1 2015$1,479,000
-19.5%
150,0000.0%0.03%
-26.2%
Q4 2014$1,838,000
+22.8%
150,0000.0%0.04%
+10.5%
Q3 2014$1,497,000
+31.8%
150,0000.0%0.04%
+26.7%
Q2 2014$1,136,000150,0000.03%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2014
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders